Obese Patients With or Without Comorbidities (RIO-North America)

NCT00029861 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3045

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Weight Loss

Interventions

DRUG: Rimonabant (SR141716)

Sponsor

Sanofi